Brandorphine

Ukkel ·KBO/BCE: BE 0781.289.765

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	22-08-2025	22 d late	2025-00391024
31-12-2023	31-07-2024	30-07-2024	1 d early	2024-00302822
31-12-2022	31-07-2023	27-07-2023	4 d early	2023-00276132

Metric	This company	Sector median	Position in the sector
Solvency	-55.3%	29.0%	better than 10% of 74 sector peers
Net result	€-8k	€12k	better than 24% of 73 sector peers
Equity	€-3k	€53k	better than 15% of 74 sector peers
Gross operating margin	€-7k	€32k	better than 14% of 63 sector peers
Total assets	€6k	€280k	better than 6% of 74 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€6k
Fixed assets	21/28	€1k
Tangible fixed assets	22/27	€1k
Current assets	29/58	€5k
Amounts receivable within one year	40/41	€915
Cash & bank	54/58	€3k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€6k
Equity	10/15	€-3k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€-5k
Amounts payable	17/49	€9k
Amounts payable within one year	42/48	€9k
Trade debts payable within one year	44	€640
Income statement
Gross operating margin	9900	€-7k
Operating result	9901	€-8k
Financial charges	65	€106
Result before taxes	9903	€-8k
Net result for the period	9904	€-8k
Result to be appropriated	9905	€-8k

Summary